PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
07-Dec-2023 United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024 Businesswire
07-Dec-2023 Merck Announces Findings from Phase 2 KeyVibe-002 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab in Previously Treated Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) Businesswire
07-Dec-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
07-Dec-2023 Amanda Newton joins RWS’s Executive Team as President of Global Content Services Businesswire
07-Dec-2023 SpyBiotech Announces First Patient Dosed in Phase I Trial of SPYVLP01 Businesswire
07-Dec-2023 Second Annual Digital Engineering Awards Celebrate Corporate Giants and Visionary Engineers Businesswire
07-Dec-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Expensify, Inc. (EXFY) on Behalf of Investors Businesswire
07-Dec-2023 Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference Businesswire
07-Dec-2023 Ligand to Host Investor and Analyst Day on December 12, 2023 in New York City Businesswire
07-Dec-2023 Validation Data on a Novel Prognostic Test Developed by GRAIL in Stage I Lung Cancer Presented at North America Conference on Lung Cancer Businesswire
06-Dec-2023 Celiac Disease Foundation Teams Up with Mark Cuban Cost Plus Drug Company Businesswire
06-Dec-2023 Parker Health Announces the Appointment of Dr. Tushar Hazra as Chief Technology Officer, and Other Key Executive Personnel Businesswire
06-Dec-2023 Global Positive Airway Pressure Devices Pipeline Analysis Report 2023: Stages of Development, Segments, Region, Regulatory Path and Key Companies - ResearchAndMarkets.com Businesswire
06-Dec-2023 Kubota Vision Announces Agreement with AUROLAB for Development, Manufacturing, Supply, and Distribution License of eyeMO Businesswire
06-Dec-2023 Kubota Vision Announces Vendor Agreement with IQVIA for eyeMO Businesswire
06-Dec-2023 Neue Post-Hoc-Analyse von Phase-3-Daten zeigt, dass AJOVY® (Fremanezumab) Migräneattacken bei Erwachsenen mit Migräne und komorbider Adipositas reduziert Businesswire
06-Dec-2023 BioStar Capital Closes Fund V at $130.3 Million, Surpassing Previous Funds Businesswire
06-Dec-2023 ThreatNG Launches Groundbreaking Open-Source Governance and Compliance Dataset Project Businesswire
06-Dec-2023 Lubrizol’s 2023 Innovations Advanced Mobility, Improved Wellbeing and Enhanced Modern Life Businesswire
06-Dec-2023 Schwarzman Scholars Announces Class of 2024-2025 Businesswire